The mutational signatures of poor treatment outcomes on the drug-susceptible Mycobacterium tuberculosis genome https://www.biorxiv.org/content/10.1101/2022.11.20.517260v1?med=mas
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.